CDSCO UID IMP/IVD/2023/000104_b5d95616456c20bc50deb405ccecdeb9_a224c7d64bf999eabc1d728fe9bcd636N-terminal Prohormone of Brain Natriuretic Peptide (N-terminal Prohormone of Brain Natriuretic Peptide )
- UID
- IMP/IVD/2023/000104_b5d95616456c20bc50deb405ccecdeb9_a224c7d64bf999eabc1d728fe9bcd636
- Device class
- Class C
- Brand name
- CLIA
- License holder
- M/s. Peerless Biotech Pvt. Ltd.
- Approving authority
- CDSCO
- Product information
- N-terminal Prohormone of Brain Natriuretic Peptide (CLIA) is a chemiluminescence immunoassay test for the quantitative measurement of circulating N-terminal prohormone of brain natriuretic peptide (CLIA) in human serum, plasma and whole blood which is intended as an aid to Diagnosis of heart failure. The detection range of this assay is 15pg/mL~35000pg/mL
N-terminal Prohormone of Brain Natriuretic Peptide (N-terminal Prohormone of Brain Natriuretic Peptide ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000104_b5d95616456c20bc50deb405ccecdeb9_a224c7d64bf999eabc1d728fe9bcd636. This device is marketed under the brand name CLIA. The license holder is M/s. Peerless Biotech Pvt. Ltd., and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.